CRISPR-associated protein Cas3 (Cas3)

CRISPR-associated protein Cas3 is the signature effector enzyme of type I CRISPR-Cas systems, common in bacteria such as *Klebsiella pneumoniae* and others[4][6][3]. Cas3 is a multi-domain protein, possessing an N-terminal HD nuclease domain and a C-terminal superfamily 2 (SF2) helicase domain, sometimes with additional accessory domains and linkers, depending on subtype[6][1][4]. It is recruited to foreign DNA recognized by the Cascade (CRISPR-associated complex for antiviral defense), where it initiates double strand DNA degradation by first nicking the non-target strand and then processively unwinding and cleaving DNA in an ATP-dependent manner[2][4][5][8]. Cas3 is not a traditional human therapeutic target like a receptor or transporter, but in biotechnology it is engineered for large genomic deletions and functional genome knockout applications[2][7]. While not directly targeted by drugs, the activity of Cas3 forms the basis of programmable bacterial immunity and genome editing systems. Regarding query accuracy, the phrase "Klebsiella pneumoniae genomic DNA via CRISPR-associated protein Cas3" is not a standard target name; it conflates the pathogen's DNA (a substrate) with the Cas3 protein (the functional enzyme)[4]. The canonical target is Cas3, not the DNA. Cas3 itself is the proper molecular target; genomic DNA of *K. pneumoniae* becomes a substrate for Cas3-directed activity, rather than being the target entity in pharmacology or molecular biology. Cas3 is an enzyme and effector in the bacterial CRISPR immune system, not a host receptor or typical therapeutic target. It is, however, a molecular tool in genome editing platforms. In summary, Cas3 is an enzyme (helicase/nuclease) central to type I CRISPR-mediated adaptive immunity, acting as a "molecular shredder" of targeted DNA[4][2][6]. It participates in *K. pneumoniae*'s defense against phages by being recruited to Cascade-bound target DNA and processively degrading it[3][9]. Cas3 has become a tool for large-scale genome editing via programmable destruction of specific DNA segments in various organisms[2][7]. When repurposed for genome editing, it may cause safety concerns like large off-target deletions[7]. While its activity could theoretically be blocked (or mimicked) by small molecules, Cas3 is not a classical drug target, and no drugs are currently developed for this purpose.

Other names

CRISPR-associated protein 3Cas3 nuclease-helicaseType I CRISPR-associated helicase/nuclease

Nuclease-mediated DNA cleavage, ATP-dependent DNA unwinding